Bevacizumab (Avastin) IV Solution from Japan
Bevacizumab is a humanized monoclonal antibody blocking VEGF, used for colorectal and lung cancer. Under HTS 3002.15.00.11 for its role in immunological regulation via angiogenesis inhibition, in retail-measured vials.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Include VEGF specificity test results and monoclonal purity assays in import docs
• Comply with USP <1079> for good distribution practices; avoid temperature excursions